Viewing Study NCT03121534


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-04-11 @ 3:52 AM
Study NCT ID: NCT03121534
Status: TERMINATED
Last Update Posted: 2023-02-17
First Post: 2017-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2016-0765
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View